Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Åberg, L.
Right arrow Articles by Santavuori, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Åberg, L.
Right arrow Articles by Santavuori, P.
Neurology 2000;54:1069-1074
© 2000 American Academy of Neurology


Articles

Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms

L. Åberg, MD, K. Liewendahl, MD, PhD, P. Nikkinen, PhD, T. Autti, MD, PhD, J. O. Rinne, MD, PhD and P. Santavuori, MD, PhD

From the Hospital for Children and Adolescents, Pediatric Neurology (Drs. Åberg and Santavuori), Laboratory Department, Division of Nuclear Medicine (Drs. Liewendahl and Nikkinen), and the Department of Radiology (Dr. Autti), the University of Helsinki; and the Department of Neurology and Turku PET Centre (Dr. Rinne), University of Turku, Finland.

Address correspondence and reprint requests to Dr. Laura Åberg, Hospital for Children and Adolescents, Pediatric Neurology, PL 280, 00029 HYKS, Finland; e-mail: laura.aberg{at}Helsinki.fi

OBJECTIVE: To explore whether striatal dopamine transporters are involved in juvenile neuronal ceroid lipofuscinosis (JNCL) with extrapyramidal signs.

METHODS: Seventeen patients with JNCL entered the study (mean age, 15 years; age range, 10 to 31 years). For clinical evaluation, the authors used the motor section of the Unified Parkinson’s Disease Rating Scale (UPDRS). For studying the density of dopamine transporters in the striatum, they employed iodine-123-labeled 2ß-carbomethoxy-3ß-(4-iodophenyl) tropane as a SPECT tracer. The SPECT images were evaluated visually, and tracer accumulation was semiquantified from transverse slices as striatum-to-cerebellum activity ratios. MRI (1.5-T) signal intensities of the striatum were measured and compared with those of the thalamus.

RESULTS: The mean UPDRS score was 20 (range, 2 to 41). On SPECT, the mean striatum-to-cerebellum uptake ratio was lower in patients than in control subjects (3.1 ± 0.6 versus 6.8 ± 1.0; p < 0.001), with the decrease being more pronounced in the putamen than in the caudate nucleus. On MRI, the mean striatum-to-thalamus signal intensity ratio was higher in patients than in control subjects (1.14 ± 0.02 versus 1.08 ± 0.02; p < 0.001). There was a negative correlation between uptake ratios in SPECT and UPDRS scores, and a positive correlation between the MRI ratios and UPDRS. The SPECT and MRI ratios also correlated significantly, providing additional evidence for the contributions of nigrostriatal, striatal, and thalamic dysfunction to the parkinsonian symptoms.

CONCLUSIONS: The observed decrease in the striatal dopamine transporter density in JNCL offers a rational basis for a trial of dopaminergic drugs in this disease.

Key words: Juvenile neuronal ceroid lipofuscinosis—SPECT—MRI—Basal ganglia.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
D. Ramirez-Montealegre and D. A. Pearce
Defective lysosomal arginine transport in juvenile Batten disease
Hum. Mol. Genet., December 1, 2005; 14(23): 3759 - 3773.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. Tyynela, T. Autti, M. Haltia, and S. E. Mole
Pirkko Santavuori (1933-2004)
J Child Neurol, June 1, 2004; 19(6): 465 - 470.
[PDF]


Home page
NeurologyHome page
L. E. Aberg, J. O. Rinne, I. Rajantie, and P. Santavuori
A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis
Neurology, May 8, 2001; 56(9): 1236 - 1239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.